SMALES KELLY received a stock award from TRANSPHORM, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 10/13/2023ACC: 0001209191-23-052774
+48.63K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
48.63K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+45.66K
Price / share
—
Trade value
—
% of position
126.2%
10/11/2023
36.17K→81.83K
Common Stock
Direct
Shares
+2.97K
Price / share
—
Trade value
—
% of position
3.6%
10/11/2023
81.83K→84.80K
Total
Net shares
+48.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/11/2023 | A · Award | +45.66K | — | — | 126.2% | 36.17K | 81.83K |
| Common Stock Direct | 10/11/2023 | A · Award | +2.97K | — | — | 3.6% | 81.83K | 84.80K |
| Total | +48.63K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported